CN101002917B - Chinese medicine for treating thromboangitis obliterans - Google Patents
Chinese medicine for treating thromboangitis obliterans Download PDFInfo
- Publication number
- CN101002917B CN101002917B CN200610150995A CN200610150995A CN101002917B CN 101002917 B CN101002917 B CN 101002917B CN 200610150995 A CN200610150995 A CN 200610150995A CN 200610150995 A CN200610150995 A CN 200610150995A CN 101002917 B CN101002917 B CN 101002917B
- Authority
- CN
- China
- Prior art keywords
- parts
- rhizoma
- radix
- chinese medicine
- fructus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A Chinese medicine for treating thromboangiitis obliterans, arteriosclerotic obliteration, aorto-arteritis and Raynaud's syndrome is prepared from 31 Chinese-medicinal materials including honeysuckle flower, red peony root, safflower, peach kernel, etc.
Description
Technical field
The present invention relates to a kind of medical technical field, be specifically related to the vasculitic Chinese medicine of a kind of treatment.
Background technology
Thromboangiitis obliterans belongs to one of China's three macroangiopathics, and its risk factor and smoking, quenching, wound etc. have substantial connection.Be cardiovascular and cerebrovascular disease another difficult disease afterwards, state of an illness stubbornness, touching difficulty heals, in case ill, often put the patient among great misery, even disable because of can not in time treating." thromboangiitis obliterans " traditional Chinese medical science claims necrosis, is segmental beading sample by the tremulous pulse of being invaded, and with the passing of time is streak, forms thrombus obstruction, causes the limbs disturbance of blood circulation, and anoxia appears in local organization, in addition fester, gangrene.Modern Chinese medicine treatment vasculitis is generally used " XUESHUANTONG " treatment, but therapeutic effect is not good; And doctor trained in Western medicine can only be taked the method for amputation, clips downright bad part, takes stopgap measures and can not effect a permanent cure.
Summary of the invention
The object of the present invention is to provide a kind of Chinese medicine for the treatment of thromboangiitis obliterans, short treating period, instant effect has no side effect, and total effective rate reaches 100%.
The present invention treats the Chinese medicine of thromboangiitis obliterans and is mainly made by the crude drug of following umber: Flos Lonicerae 4-6 part, Caulis Spatholobi 4-6 part, Radix Paeoniae Rubra 4-6 part, Radix Angelicae Sinensis 4-6 part, Herba Taraxaci 4-6 part, Flos Carthami 1-4 part, Semen Persicae 1-4 part, rhizoma sparganic 1-4 part, Rhizoma Curcumae 1-4 part, Fructus Chaenomelis 1-4 part, Eupolyphaga Seu Steleophaga 1-4 part, Herba Dendrobii 4-6 part, Radix Achyranthis Bidentatae 1-4 part, Radix Astragali 2-4 part, pollen 4-6 part, Radix Scrophulariae 4-6 part, Squama Manis 1-2 part, Rhizoma Corydalis 1-3 part, Olibanum 1-3 part, Myrrha 1-3 part, Radix Stephaniae Tetrandrae 1-4 part, Fructus Toosendan 4-6 part, Ramulus Mori 4-6 part, Ramulus Cinnamomi 2-4 part, Rhizoma Chuanxiong 1-4 part, Pheretima 1-4 part, Rhizoma Atractylodis Macrocephalae 1-4 part, Resina Toxicodendri 2-4 part, Hirudo 1-2 part, Rhizoma Zingiberis 1-2 part and Radix Glycyrrhizae 1-4 part.
Chinese medicine of the present invention is with Flos Lonicerae, Caulis Spatholobi, Radix Paeoniae Rubra, Herba Taraxaci, when being classified as principal agent.Wherein Flos Lonicerae, Herba Taraxaci have the effect of heat-clearing and toxic substances removing, and to the dissipation carbuncle, sore has better curative effect; Radix Angelicae Sinensis is enriched blood and is invigorated blood circulation, and holds up empty benefit to decrease the effect of removing blood stasis tissue regeneration promoting; Radix Paeoniae Rubra, Caulis Spatholobi two medicines share the stasis of blood in the blood that looses, the relaxing muscles and tendons to promote blood circulation collateral dredging of enriching blood, the hard detumescence of bursting.
Auxilliary using: Flos Carthami, Semen Persicae, rhizoma sparganic, Rhizoma Curcumae, Hirudo, Resina Toxicodendri, wherein, Flos Carthami, Semen Persicae two medicines of distinguishing the flavor of share repercussive heat and QI and blood with tissue regeneration promoting.The two is same with the pain relieving of sharp blood removing food stagnancy for rhizoma sparganic, Rhizoma Curcumae.Hirudo eliminating stagnation softening the hard mass, removing blood stasis.The Resina Toxicodendri dissipating blood stasis breaks abdominal mass, strengthens the removing blood stasis hard effect that disappears.
Assistant is used: Fructus Chaenomelis, Eupolyphaga Seu Steleophaga, Herba Dendrobii, Radix Achyranthis Bidentatae.The Fructus Chaenomelis sour in the mouth, warm in nature, acid and go into liver, beneficial muscle and blood; Eupolyphaga Seu Steleophaga goes into blood softening the hard mass, relaxing muscles and tendons to promote blood circulation; The Herba Dendrobii sweet in the mouth, cold nature is with cold yin nourishing; Radix Achyranthis Bidentatae has invigorating the liver and kidney, and the effect of ailment said due to cold or exposure is gone in bone and muscle strengthening.Four medicines share remuval of damp and hot, the bone strengthening tonify deficiency, and relaxing muscles and tendons to promote blood circulation goes the wind pain relieving.
Because the patient has a delicate constitution, QI and blood is originally not enough, so assistant also has with flavour of a drug: the Radix Astragali, Radix Scrophulariae, Rhizoma Atractylodis Macrocephalae inrigorating qi and promoting blood circulation; Be apt to away scurry with its property of Squama Manis, merit specially row is loose; Pollen evacuation of pus removing the necrotic tissue and promoting granulation closes up.The Radix Astragali, Rhizoma Atractylodis Macrocephalae QI invigorating are given birth to cloudy, and dampnessization is turbid; Capable the stagnating of Rhizoma Corydalis removed resistance, eliminating stasis to stop pain; The heat clearing away of Fructus Toosendan dampness; Olibanum, Myrrha blood circulation promoting regulates qi, the pain relieving granulation promoting; Radix Stephaniae Tetrandrae, Rhizoma Zingiberis are transferred cold air, warming spleen and stomach for dispelling cold, and recuperating depleted YANG is promoted blood circulation.With Ramulus Mori, Ramulus Cinnamomi, Rhizoma Chuanxiong, Pheretima, dispeling the wind relieves dizziness, high fever, infantile convulsions, epilepsy, etc., and searches liver-wind again, tonifying liver blood; The Ramulus Mori dispelling wind and removing obstruction in the collateral, Ramulus Cinnamomi promoting the flow of QI in the collateral by warming the meridian, Rhizoma Chuanxiong blood-activating and qi-promoting, wind-expelling pain-stopping; Pheretima is searched wind and enriches blood, the Radix Glycyrrhizae coordinating the actions of various ingredients in a prescription.More than all medicine compatibilities, have heat-clearing and toxic substances removing, blood circulation and channel invigorating, blood stasis removing embolism extinguishing, relieve dizziness, high fever, infantile convulsions, epilepsy, etc. and enrich blood, the effect of eliminating pathogenic factor for supporting vital QI is so close cold vasculitis to the treatment thrombosis, short treating period, curative effect is fast, and atherosclerotic occlusive disease, Takayasu arteritis, Reynolds syndrome etc. are all had significant curative effect.
Preparation technology of the present invention is: with above-mentioned Chinese medicine routinely pharmaceutical methods make pill or make other dosage form.The every ball of pill weigh 10 the gram, every day secondary, each two balls; Decoction is decocted in water for oral dose, every day secondary, each 100 milliliters.
The specific embodiment
Preferably: 2 parts in 5 parts of Flos Loniceraes, 5 parts of Caulis Spatholobis, 5 parts of Radix Paeoniae Rubra, 5 parts of Radix Angelicae Sinensis, 5 parts of Herba Taraxacis, 2 parts on Flos Carthami, 2 parts in Semen Persicae, 2 parts of rhizoma sparganic, 2 parts of Rhizoma Curcumae, 2 parts of Fructus Chaenomeliss, 2 parts of Eupolyphaga Seu Steleophagas, 5 parts of Herba Dendrobiis, 2 parts of Radix Achyranthis Bidentataes, 3 parts of the Radixs Astragali, 5 parts of pollen, 5 parts of Radix Scrophulariae, 1 part of Squama Manis, 1.5 parts of Rhizoma Corydalis, 1.5 parts of Olibanums, 1.5 parts of Myrrhas, 2 parts of Radixs Stephaniae Tetrandrae, 5 parts of Fructus Toosendans, 5 parts of Ramulus Moris, 3 parts of Ramulus Cinnamomi, 2 parts of Rhizoma Chuanxiongs, 2 parts of Pheretimas, 2 parts of the Rhizoma Atractylodis Macrocephalaes, 3 parts of Resina Toxicodendri, 1 part of Hirudo, 1 part of Rhizoma Zingiberis and Radix Glycyrrhizae are ground into powder and add Mel and make pill for 10 parts.
Use the clinical experiment report of Chinese medicine of the present invention:
1. physical data: thromboangiitis obliterans patient's 100 examples, male's 80 examples, 20~40 years old age; Women's 20 examples, 30~50 years old age.
2. diagnostic criteria: the patient has lower limb to carry out that walk lamely sexual refractoriness and the chronic ischemia symptom more, as numbness, be afraid of cold, pain, performance such as pale.Suffer from limb pain and aggravate gradually, acra skin is sent out cold, raises that then color is pale, erubescence, dark red, livid purple then during lower limb.The medium and small arteriopalmus of trouble limb weakens or disappears, and the later stage, dryness or moist necrosis then took place.
3, Therapeutic Method: take the present invention and treat thromboangiitis obliterans Chinese medicine---the healthy and free from worry pill of arteries and veins, a twice-daily, each two balls, one month is a course of treatment.
4, curative effect determinate standard: recovery from illness: clinical symptoms disappears substantially, and the limbs wound surface heals fully, and limbs peripheral blood circulatory disturbance is obviously improved; Produce effects: clinical symptoms is obviously improved; Limbs wound healing or approaching healing; Limbs peripheral blood circulatory disturbance has improvement; Invalid: as to treat after 1 course of treatment clinical symptoms and sign is not improved or the state of an illness continues development person.
5, result: take Chinese medicine of the present invention after 7 days, effectively the cracking sludged blood is progressively disintegrated phlebothrombosis, and venous backflow is accelerated, and swelling, pain, numb limbs and tense tendons all alleviate fast.After taking a course of treatment, make vein blood vessel progressively unimpeded, blood circulation quickens, and swelling is eliminated fully, and is painless.After taking two courses of treatment, endothelial cell obtains Regeneration and Repair, the smooth smoothness of vein blood vessel, and the elasticity Regeneration and Repair, the blood vessel that curls recovers, and vein group unfolds to loose and separates clinical symptom disappearance.New muscle grows, nerve fiber regeneration, and the neuroregulation ability is recovered.
The present invention uses through 100 routine patients clinicals, 94 examples of fully recovering, and produce effects 6 examples, invalid 0 example, cure rate reaches 94%, and total effective rate reaches more than 100%, has no side effect.
Claims (2)
1. Chinese medicine for the treatment of thromboangiitis obliterans, it is characterized in that: it is to be made by the crude drug of following umber: Flos Lonicerae 4-6 part, Caulis Spatholobi 4-6 part, Radix Paeoniae Rubra 4-6 part, Radix Angelicae Sinensis 4-6 part, Herba Taraxaci 4-6 part, Flos Carthami 1-4 part, Semen Persicae 1-4 part, rhizoma sparganic 1-4 part, Rhizoma Curcumae 1-4 part, Fructus Chaenomelis 1-4 part, Eupolyphaga Seu Steleophaga 1-4 part, Herba Dendrobii 4-6 part, Radix Achyranthis Bidentatae 1-4 part, Radix Astragali 2-4 part, pollen 4-6 part, Radix Scrophulariae 4-6 part, Squama Manis 1-2 part, Rhizoma Corydalis 1-3 part, Olibanum 1-3 part, Myrrha 1-3 part, Radix Stephaniae Tetrandrae 1-4 part, Fructus Toosendan 4-6 part, Ramulus Mori 4-6 part, Ramulus Cinnamomi 2-4 part, Rhizoma Chuanxiong 1-4 part, Pheretima 1-4 part, Rhizoma Atractylodis Macrocephalae 1-4 part, Resina Toxicodendri 2-4 part, Hirudo 1-2 part, Rhizoma Zingiberis 1-2 part and Radix Glycyrrhizae 1-4 part.
2. a kind of Chinese medicine for the treatment of thromboangiitis obliterans according to claim 1 is characterized in that: it is to be made by the following raw materials in weight medicine: 5 parts of Flos Loniceraes, 5 parts of Caulis Spatholobis, 5 parts of Radix Paeoniae Rubra, 5 parts of Radix Angelicae Sinensis, 5 parts of Herba Taraxacis, 2 parts on Flos Carthami, 2 parts in Semen Persicae, 2 parts of rhizoma sparganic, 2 parts of Rhizoma Curcumae, 2 parts of Fructus Chaenomeliss, 2 parts of Eupolyphaga Seu Steleophagas, 5 parts of Herba Dendrobiis, 2 parts of Radix Achyranthis Bidentataes, 3 parts of the Radixs Astragali, 5 parts of pollen, 5 parts of Radix Scrophulariae, 1 part of Squama Manis, 1.5 parts of Rhizoma Corydalis, 1.5 parts of Olibanums, 1.5 parts of Myrrhas, 2 parts of Radixs Stephaniae Tetrandrae, 5 parts of Fructus Toosendans, 5 parts of Ramulus Moris, 3 parts of Ramulus Cinnamomi, 2 parts of Rhizoma Chuanxiongs, 2 parts of Pheretimas, 2 parts of the Rhizoma Atractylodis Macrocephalaes, 3 parts of Resina Toxicodendri, 1 part of Hirudo, 2 parts in 1 part of Rhizoma Zingiberis and Radix Glycyrrhizae.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200610150995A CN101002917B (en) | 2006-11-04 | 2006-11-04 | Chinese medicine for treating thromboangitis obliterans |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200610150995A CN101002917B (en) | 2006-11-04 | 2006-11-04 | Chinese medicine for treating thromboangitis obliterans |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101002917A CN101002917A (en) | 2007-07-25 |
CN101002917B true CN101002917B (en) | 2010-05-19 |
Family
ID=38702443
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200610150995A Expired - Fee Related CN101002917B (en) | 2006-11-04 | 2006-11-04 | Chinese medicine for treating thromboangitis obliterans |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101002917B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103285360B (en) * | 2013-06-09 | 2014-09-17 | 王京涛 | Traditional Chinese medicinal preparation for treating thromboangiitis obliterans, and preparation method thereof |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102008684B (en) * | 2010-11-14 | 2012-06-06 | 王爱华 | Traditional Chinese medicine composition for curing level-IV chemotherapeutic phlebitis |
CN102688411A (en) * | 2012-06-11 | 2012-09-26 | 宁同波 | Chinese medicinal preparation for treating temporal arteritis |
CN102697963B (en) * | 2012-06-12 | 2014-03-19 | 尹燕 | Traditional Chinese medicine composition for curing Raynaud's disease |
CN102727724B (en) * | 2012-07-09 | 2013-09-04 | 凡府地 | Traditional Chinese medicine composition for dissolving thrombus and preparation method of composition |
CN102872258B (en) * | 2012-08-29 | 2013-11-13 | 杨剑礼 | Externally applied drug for curing thromboangiitis obliterans |
CN102784332B (en) * | 2012-09-01 | 2014-03-12 | 张德昌 | Medicine for treating angiitis |
CN102895370A (en) * | 2012-09-13 | 2013-01-30 | 魏喜成 | Traditional Chinese medicine for treating vasculitis and preparation method thereof |
CN102885896B (en) * | 2012-11-06 | 2014-10-22 | 王向飞 | Medicine for treating thromboangitis obliterans |
CN104043087A (en) * | 2014-06-25 | 2014-09-17 | 梁黎明 | Traditional Chinese medicine composition for treating Raynaud syndrome |
CN104042982A (en) * | 2014-06-26 | 2014-09-17 | 李涛 | Traditional Chinese medicine composition for treating angitis and preparation method thereof |
CN104491324A (en) * | 2014-12-04 | 2015-04-08 | 刘栋 | Aerosol for postoperative patient to promote blood circulation and remove obstruction in channels |
CN104383510A (en) * | 2014-12-05 | 2015-03-04 | 毛华养 | Traditional Chinese medicine mixture for treating Raynaud's disease |
CN105770475A (en) * | 2016-04-18 | 2016-07-20 | 邢明宇 | Traditional Chinese medicine composition for treating angiitis |
CN106138744A (en) * | 2016-08-23 | 2016-11-23 | 万龙 | A kind of Chinese medicine preparation treating liver-kidney Yin deficiency type giant cell arteritis |
CN111529665A (en) * | 2020-05-21 | 2020-08-14 | 仲崇允 | A Chinese medicinal composition for treating angiitis and varicosis |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1249191A (en) * | 1998-09-29 | 2000-04-05 | 单臣基 | Powdered medicine for treating vasculitis and its preparing process |
CN1679843A (en) * | 2005-01-27 | 2005-10-12 | 朱腾月 | Oral medicine for treating thromboangitis obliterans |
-
2006
- 2006-11-04 CN CN200610150995A patent/CN101002917B/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1249191A (en) * | 1998-09-29 | 2000-04-05 | 单臣基 | Powdered medicine for treating vasculitis and its preparing process |
CN1679843A (en) * | 2005-01-27 | 2005-10-12 | 朱腾月 | Oral medicine for treating thromboangitis obliterans |
Non-Patent Citations (4)
Title |
---|
郑尚雪.血栓闭塞性脉管炎中医治疗进展.中国中医药信息杂志2 11.1995,2(11),24-27. |
郑尚雪.血栓闭塞性脉管炎中医治疗进展.中国中医药信息杂志2 11.1995,2(11),24-27. * |
郭勇义等.血栓闭塞性脉管炎的中医药内治法研究进展.河南中医学院学报19 1.2004,19(1),83-85. |
郭勇义等.血栓闭塞性脉管炎的中医药内治法研究进展.河南中医学院学报19 1.2004,19(1),83-85. * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103285360B (en) * | 2013-06-09 | 2014-09-17 | 王京涛 | Traditional Chinese medicinal preparation for treating thromboangiitis obliterans, and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN101002917A (en) | 2007-07-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101002917B (en) | Chinese medicine for treating thromboangitis obliterans | |
CN100341545C (en) | Oral medicine for treating thromboangitis obliterans | |
CN101972453B (en) | Chinese medicinal liquor for treating rheumatic and rheumatoid arthritis and preparation method thereof | |
CN100488549C (en) | Externally applied medicament for treating rheumatism | |
CN102178800B (en) | Chinese medicine composition for treating rheumatoid arthritis and preparation method thereof | |
CN102091236A (en) | Traditional Chinese medicinal composition for treating vasculitis | |
CN102552759A (en) | Traditional Chinese medicinal composition for treating swelling and pain caused by fracture | |
CN102784333B (en) | Traditional Chinese medicine composition for curing eczema | |
CN104043087A (en) | Traditional Chinese medicine composition for treating Raynaud syndrome | |
CN104324340B (en) | It is a kind of to treat Chinese medicine preparation of heel bone hyperosteogeny and preparation method thereof | |
CN102048900A (en) | Traditional Chinese medicine preparation for treating lumbar intervertebral disc protrusion | |
CN104127567B (en) | A kind of Chinese medicine composition for the treatment of diabetic peripheral neuropathy | |
CN104771527A (en) | Traditional Chinese medicine for treating varicosity | |
CN104042982A (en) | Traditional Chinese medicine composition for treating angitis and preparation method thereof | |
CN103585483B (en) | Traditional Chinese medicine composition for treating knee osteoarthritis and preparation method of same | |
CN103463397B (en) | Traditional Chinese medicine composition for treating deficiency of kidney-yin | |
CN103550533B (en) | Chinese medicine composition for treating headache during menstruation | |
CN105267415A (en) | Traditional Chinese medicine composition for treating osteomyelitis | |
CN102512543B (en) | Chinese medicinal composition for treating rheumatoid arthritis | |
CN104524080A (en) | Traditional Chinese medicine preparation for treating injuries from falls, fractures, contusions and strains and preparation method | |
CN104173584A (en) | Traditional Chinese medicine for treating rheumatism | |
CN104027662A (en) | Traditional Chinese medicine for treating diabetic foot and preparing method thereof | |
CN103520429A (en) | Traditional Chinese medicinal preparation used for treating rheumatic loin and leg pains | |
CN102727847B (en) | Preparation method for Chinese herbal lotion used for treating excessive-drinking caused trichomonas vaginitis | |
CN105943989A (en) | Traditional Chinese medicine composition for treating nonliquefaction of semen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100519 Termination date: 20101104 |